References
- 1. V. Juškaite, K. Ramanauskiene and V. Briedis, Testing of resveratrol microemulsion photostability and protective effect against UV induced oxidative stress, Acta Pharm. 67 (2017) 247–256; https://doi.org/10.1515/acph-2017-0018
- 2. D. de Sá Coutinho, M. T. Pacheco, R. L. Frozza and A. Bernardi, Anti-inflammatory effects of resveratrol: Mechanistic insights, Int. J. Mol. Sci. 19 (2018) Article ID 1812 (25 pages); https://doi.org/10.3390/ijms19061812
- 3. M. Glehr, M. Breisach, S. Walzer, B. Lohberger, F. Fürst, J. Friesenbichler, B. Rinner, A. Avian, R. Windhager and A. Leithner, The influence of resveratrol on the synovial expression of matrix metalloproteinases and receptor activator of NF-κB ligand in rheumatoid arthritis fibroblast-like synoviocytes, Z. Naturforsch. C 68 (2013) 336–342.
- 4. X. Chen, J. Lu, M. An, Z. Ma, H. Zong and J. Yang, Anti-inflammatory effect of resveratrol on adjuvant arthritis rats with abnormal immunological function via the reduction of cyclooxygenase-2 and prostaglandin E2, Mol. Med. Rep. 9 (2014) 2592–2598; https://doi.org/10.3892/mmr.2014.2070
- 5. J. Tian, J. W. Chen, J. S. Gao, L. Li and X. Xie, Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway, Rheumatol. Int. 33 (2013) 1829–1835; https://doi.org/10.1007/s00296-012-2657-0
- 6. J. M. López-Nicolás and F. García-Carmona, Aggregation state and pKa values of (E)-resveratrol as determined by fluorescence spectroscopy and UV-visible absorption, J. Agr. Food Chem. 56 (2008) 7600–7605; https://doi.org/10.1021/jf800843e
- 7. K. Robinson, C. Mock and D. Liang, Pre-formulation studies of resveratrol, Drug Dev. Ind. Pharm. 41 (2015) 1464–1469; https://doi.org/10.3109/03639045.2014.958753
- 8. J. Ghuman, P. A. Zunszain, I. Petitpas, A. A. Bhattacharya, M. Otagiri and S. Curry, Structural basis of the drug-binding specificity of human serum albumin, J. Mol. Biol. 353 (2005) 38–52; https://doi.org/10.1016/j.jmb.2005.07.075
- 9. N. Chandna, S. Kumar, P. Kaushik, D. Kaushik, S. K. Roy, G. K. Gupta, S. M. Jachak, J. K. Kapoor and P. K. Sharma, Synthesis of novel celecoxib analogues by bioisosteric replacement of sulfon-amide as potent anti-inflammatory agents and cyclooxygenase inhibitors, Bioorg. Med. Chem. 21 (2013) 4581–4590; https://doi.org/10.1016/j.bmc.2013.05.029
- 10. T. Kisková, R. Jendželovský, E. Rentsen, A. Maier-Salamon, N. Kokošová, Z. Papčová, J. Mikeš, P. Orendáš, B. Bojková, P. Kubatka, M. Svoboda, K. Kajo, P. Fedoročko, W. Jäger, C. Ekmekcioglu, M. Kassayová and T. Thalhammer, Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats, Eur. J. Cancer Prev. 23 (2014) 506–513; https://doi.org/10.1097/CEJ.0000000000000083
- 11. M. E. Weinblat, J. M. Kremer, J. S. Coblyn, A. L. Maier, S. M. Helfgott, M. Morrell, V. M. Byrne, M. V. Kaymakcian and V. Strand, Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis, Arthritis Rheumatol. 42 (1999) 1322–1328.
- 12. I. Petitpas, A. A. Bhattacharya, S. Twine, M. East and S. Curry, Crystal structure analysis of warfarin binding to human serum albumin: Anatomy of drug site I, J. Biol. Chem. 276 (2001) 22804–22809.
- 13. J. K. Maier and P. Labute, Assessment of fully automated antibody homology modeling protocols in molecular operating environment, Proteins 82 (2014) 1599–1610.
- 14. H. S. Larsen, P. K. Chin, E. J. Begg and B. P. Jensen, Quantification of total and unbound concentrations of lorazepam, oxazepam and temazepam in human plasma by ultrafiltration and LC-MS/MS. Bioanalysis 3 (2011) 843–852; https://doi.org/10.4155/bio.11.46
- 15. J. Chen, H. Wu, G. B. Xu, M. M. Dai, S. L. Hu, L. L. Sun, W. Wang, R. Wang, S. P. Li and G. Q. Li, Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies, J. Pharm. Biomed. Anal. 108 (2015) 122–128; https://doi.org/10.1016/j.jpba.2015.01.044